Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Treatment of MEFs with WM-1119 results in cell cycle arrest in G1 and a senescence phenotype similar to that seen upon treatment with WM-8014
male HBV transgenic mice) treatment markedly suppresses the level of HBV DNA and 3
TH287 could act as a chemotherapeutic agent for cancer research
this caspase-1 inhibitor induced a decrease with 6 ppm Co2+
SNIPER(TACC3)-2 targets the TACC3 protein for degradation via the ubiquitin-proteasome pathway
ALK5 Inhibitor II (hydrochloride) Catalog No.:M23387-C Treatment of MEFs with WM-1119IC50: 4, 18, and 23 nM for ALK5 autophosphorylation, TGF cellular assay, and ALK5 binding in HepG2 cells, respectively ALK5 Inhibitor II is an ALK5 inhibitor. The TGF beta family of cytokines signal via serine threonine kinase transmembrane type I and type II receptors. Binding TGF beta1 to the receptor complex triggers activation of activin receptor like kinase (ALK), initiating downstream signaling involving Smad transcription factors, mitogen
US$ 174.50
US$ 299.50
US$ 14.95
US$ 114.00
US$ 199.50
US$ 37.00
US$ 65.00
US$ 38.00
US$ 124.50
US$ 38.00
US$ 68.00
US$ 120.00
US$ 57.00
US$ 38.00
US$ 54.00